Athersys Inc (ATHXQ)

[xrhodie]

Finally we see the Masters-2 trial going here in the States and Europe is added. 300 patients to go, but still I maintain that the 3 month assessment in these studies will give results that need addressing for some sort of permission allowing wider usage. Read the Athersys announcement. What other reason to be given 3 or 4 special designations from the FDA, which is emphasized as a header in the web announcement.